title: Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms.
abstract: Three simple and sensitive spectrophotometric methods were developed and validated for determination of the hydrochloride salts of fluoxetine, sertraline, and paroxetine in their pharmaceutical dosage forms. These methods were based on the reaction of the N-alkylvinylamine formed from the interaction of the free secondary amino group in the investigated drugs and acetaldehyde with each of 3 haloquinones, i.e., chloranil, bromanil, and 2,3-dichloronaphthoquinone, to give colored vinylamino-substituted quinones. The colored products obtained with chloranil, bromanil, and 2,3-dichloronaphthoquinone exhibit absorption maxima at 665, 655, and 580 nm, respectively. The factors affecting the reactions were studied and optimized. Under the optimum reaction conditions, linear relationships with good correlation coefficients (0.9986-0.9999) were found between the absorbances and the concentrations of the investigated drugs in the range of 4-120 microg/mL. The limits of detection for the assays ranged from 1.19 to 2.98 microg/mL. The precision values of the methods were satisfactory; the relative standard deviations were 0.56-1.24%. The proposed methods were successfully applied to the determination of the 3 drugs in pure and pharmaceutical dosage forms with good accuracy; the recoveries ranged from 99.1 to 101.3% with standard deviations of 1.15-1.92%. The results compared favorably with those of reported methods.
authors.affiliation: Assiut University, Faculty of Pharmacy, Department of Pharmaceutical Analytical Chemistry, Assiut 71526, Egypt. iadarwish@yahoo.com
authors.forename: Ibrahim A
authors.initials: IA
authors.lastname: Darwish
mesh_terms: D000079:Acetaldehyde / Q000737:chemistry; D016227:Benzoquinones / Q000032:analysis*; D002623:Chemistry Techniques, Analytical / Q000379:methods*; D002703:Chloranil / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D005473:Fluoxetine / Q000032:analysis*; D008956:Models, Chemical; D009285:Naphthoquinones / Q000737:chemistry; D017374:Paroxetine / Q000032:analysis*; D004364:Pharmaceutical Preparations; D010616:Phenanthrenes / Q000737:chemistry; D011786:Quality Control; D011809:Quinones / Q000737:chemistry; D012680:Sensitivity and Specificity; D017367:Selective Serotonin Reuptake Inhibitors / Q000032:analysis*; D020280:Sertraline / Q000032:analysis*; D013053:Spectrophotometry / Q000379:methods*; D013997:Time Factors
chemical_list: D000079:Acetaldehyde; D016227:Benzoquinones; D002703:Chloranil; D005473:Fluoxetine; D009285:Naphthoquinones; D017374:Paroxetine; D004364:Pharmaceutical Preparations; D010616:Phenanthrenes; D011809:Quinones; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; C502343:bromanil; C033791:haloquinone; C007332:dichlone